Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma

Clinical trial NCT03317457 · COMPLETED

Trial details

NCT number: NCT03317457
Sponsor: AIO-Studien-gGmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Adult Soft Tissue Sarcoma Recurrent Adult Soft Tissue Sarcoma

Start date: 2017-12-15
Primary completion: 2022-08-12
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.